Liver Health Panel

The Liver Health Panel is a blood test that measures three enzymes commonly assessed when reviewing possible liver or bile duct changes: aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT). It can be used as an initial laboratory check during preventive testing, when liver-related risk factors are present, or when previous blood results require follow-up.

The panel provides information about enzyme activity in a serum sample. It does not diagnose a specific liver condition and should not be interpreted independently of symptoms, medical history, medications, alcohol intake, previous results, and other relevant tests.

What the Liver Health Panel measures

AST, ALT, and GGT are enzymes found in the liver, although they are not limited exclusively to liver tissue. Their levels may change when liver cells, bile ducts, muscles, or other tissues are affected.

• ALT is found mainly in the liver and may rise when liver cells are irritated or damaged.
• AST is present in the liver as well as muscles, the heart, and other tissues, so an elevated value is not automatically specific to the liver.
• GGT is associated with the liver and bile ducts and may be interpreted together with other tests when a possible hepatobiliary change is being assessed.

The relationship between the three values can be more informative than one isolated result. Even so, the panel represents only one part of a broader clinical assessment.

When the panel may be considered

This test may be considered as part of a preventive laboratory check, after previously elevated liver enzymes, or when a clinician wants to monitor laboratory changes over time. It may also be relevant for people with metabolic risk factors, regular alcohol exposure, use of medications or supplements that may affect the liver, or a known condition requiring periodic monitoring.

Some people seek testing because of fatigue and low energy. Fatigue is a nonspecific symptom with many possible causes, including sleep problems, anemia, infection, hormonal changes, metabolic conditions, psychological stress, medication effects, and other health issues. Fatigue alone does not indicate liver disease, and this panel cannot determine its cause by itself.

Symptoms such as yellowing of the skin or eyes, dark urine, pale stool, persistent itching, nausea, reduced appetite, or discomfort in the upper right abdomen may require medical assessment. Laboratory testing can support that assessment, but the choice of tests should reflect the full clinical situation.

How the testing process works

Step 1: Review the reason for testing

Before testing, it is useful to clarify whether the panel is being performed preventively, because of symptoms, to review a previous abnormal result, or to monitor an existing condition. Previous laboratory reports can help identify changes over time.

Step 2: Prepare for the blood draw

A fasting serum sample is required. Follow the fasting instructions provided before the appointment. Regular medication should not be stopped or changed unless a doctor has specifically advised this.

Step 3: Provide the blood sample

A venous blood sample is collected and processed to obtain serum. The serum is then analyzed for AST, ALT, and GGT.

Step 4: Receive the laboratory report

The results are available the same day. The report shows the measured values and the applicable reference intervals. Reference ranges may vary according to the analytical method and patient-related factors.

Step 5: Decide whether follow-up is needed

An abnormal result does not identify the cause on its own. Depending on the pattern and degree of change, follow-up may include repeat testing, additional blood tests, medication review, clinical examination, or imaging. The appropriate next step depends on the overall medical context.

Understanding the results

Elevated ALT or AST may indicate liver cell injury, but the level of elevation does not directly show how much functional capacity the liver has retained. AST can also increase because of changes involving muscle or other tissues. An elevated GGT result may support further evaluation of the liver or bile ducts but is not specific enough to establish a diagnosis independently.

Results within the reference range are generally reassuring, but a normal panel does not exclude every liver disease. Some liver conditions may be present with normal or intermittently normal enzyme levels, especially during certain stages of disease. Symptoms, risk factors, physical examination, imaging, and other laboratory markers may still be relevant.

What this panel does not measure

AST, ALT, and GGT are commonly described as liver enzymes, but they do not directly measure all liver functions. The panel does not include markers such as bilirubin, albumin, total protein, alkaline phosphatase, or prothrombin time. These tests assess different aspects of liver processing, protein production, bile flow, and blood clotting.

If a broader review is needed, additional tests may be recommended. The choice should be based on symptoms, previous findings, medication exposure, medical history, and the reason for testing rather than on one enzyme value alone.

What to prepare before sending an inquiry

When requesting the test, include the reason for testing, any symptoms and how long they have been present, previous AST, ALT, or GGT results, diagnosed conditions, and a list of medications and supplements. Mention whether the test was recommended by a doctor and whether other liver-related tests or imaging have already been performed.

You can send ZagrebMed this information and any available medical reports to request the Liver Health Panel in Zagreb. ZagrebMed can also help clarify whether the requested basic panel matches your referral or whether medical advice about a broader assessment may be appropriate.